PGx to Play Role in Pfizer Drug Repositioning Partnership with Wash U

Under the five-year, $22.5 million partnership, Wash U researchers will investigate molecular-level mechanisms of compounds in Pfizer's pipeline and will seek to identify genetic variations linked to patient response.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.